George C, Carlet J, Sobel A, Intrator L, Robin M, Sabatier C
Intensive Care Med. 1980; 6(2):123-7.
PMID: 7365108
DOI: 10.1007/BF01683357.
ORSKOV F, Larsen J, ORSKOV I
Med Microbiol Immunol. 1981; 170(2):117-33.
PMID: 7033750
DOI: 10.1007/BF02122676.
Belsheim J, Gnarpe H, Kaijser B
Infect Immun. 1981; 31(1):7-10.
PMID: 7012007
PMC: 351744.
DOI: 10.1128/iai.31.1.7-10.1981.
Larsson P, Kaijser B, Baltzer I, Olling S
J Clin Pathol. 1980; 33(4):408-12.
PMID: 6995491
PMC: 1146089.
DOI: 10.1136/jcp.33.4.408.
Horwitz M, Silverstein S
J Clin Invest. 1980; 65(1):82-94.
PMID: 6985617
PMC: 371342.
DOI: 10.1172/JCI109663.
Opsonization of various capsular (K) E. coli by the alternative complement pathway.
Stevens P, Young L, Adamu S
Immunology. 1983; 50(3):497-502.
PMID: 6354922
PMC: 1454253.
Protection against acute, ascending pyelonephritis caused by Escherichia coli in rats, using isolated capsular antigen conjugated to bovine serum albumin.
Kaijser B, Larsson P, Olling S, Schneerson R
Infect Immun. 1983; 39(1):142-6.
PMID: 6337094
PMC: 347916.
DOI: 10.1128/iai.39.1.142-146.1983.
Structure of the Escherichia coli K2 capsular antigen, a teichoic acid-like polymer.
Jann K, JANN B, Schmidt M, Vann W
J Bacteriol. 1980; 143(3):1108-15.
PMID: 6251025
PMC: 294457.
DOI: 10.1128/jb.143.3.1108-1115.1980.
Immunization against retrograde pyelonephritis. II. Prevention of retrograde Escherichia coli pyelonephritis with vaccines.
Brooks S, Lyons J, BRAUDE A
Am J Pathol. 1974; 74(2):359-64.
PMID: 4590646
PMC: 1910770.
Urinary antibody response after immunisation with a vaccine against urinary tract infection.
KRUZE D, Holzbecher K, ANDRIAL M, Bossart W
Urol Res. 1989; 17(6):361-6.
PMID: 2623792
DOI: 10.1007/BF00510527.
Virulence factors in Escherichia coli urinary tract infection.
Johnson J
Clin Microbiol Rev. 1991; 4(1):80-128.
PMID: 1672263
PMC: 358180.
DOI: 10.1128/CMR.4.1.80.
Protection by a polyvalent vaccine against challenge infection and pyelonephritis.
KRUZE D, Biro K, Holzbecher K, ANDRIAL M, Bossart W
Urol Res. 1992; 20(2):177-81.
PMID: 1553795
DOI: 10.1007/BF00296534.
Experimental Escherichia coli O6 pyelonephritis in rabbits. Effect on O6 antibody quantity and avidity of prior immunization with E. coli O2 bacteria.
Ahlstedt S, Kaijser B
Immunology. 1975; 28(5):841-6.
PMID: 1093966
PMC: 1445913.
The local immune response to Escherichia coli O and K antigen in experimental pyelonephritis.
Smith J, Kaijser B
J Clin Invest. 1976; 58(2):276-81.
PMID: 783196
PMC: 333180.
DOI: 10.1172/JCI108469.
Antigen presentation as a factor in the protective immune response to renal infection.
Miller T, Burnham S
Clin Exp Immunol. 1975; 22(2):265-78.
PMID: 765022
PMC: 1538299.
Antipili antibody affords protection against experimental ascending pyelonephritis.
Silverblatt F, Cohen L
J Clin Invest. 1979; 64(1):333-6.
PMID: 376560
PMC: 372123.
DOI: 10.1172/JCI109458.
Protection against ascending Escherichia coli pyelonephritis in rats and significance of local immunity.
Kaijser B, Larsson P, Olling S
Infect Immun. 1978; 20(1):78-81.
PMID: 352939
PMC: 421554.
DOI: 10.1128/iai.20.1.78-81.1978.
Structure and serological specificity of the K13-antigenic polysaccharide (K13 antigen) of urinary tract-infective Escherichia coli.
Vann W, Jann K
Infect Immun. 1979; 25(1):85-92.
PMID: 90016
PMC: 414424.
DOI: 10.1128/iai.25.1.85-92.1979.
Protective capacity of antibodies against Escherichia coli and K antigens.
Kaijser B, Ahlstedt S
Infect Immun. 1977; 17(2):286-9.
PMID: 70410
PMC: 421116.
DOI: 10.1128/iai.17.2.286-289.1977.
